These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24802772)

  • 21. Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis.
    Caganova M; Carrisi C; Varano G; Mainoldi F; Zanardi F; Germain PL; George L; Alberghini F; Ferrarini L; Talukder AK; Ponzoni M; Testa G; Nojima T; Doglioni C; Kitamura D; Toellner KM; Su IH; Casola S
    J Clin Invest; 2013 Dec; 123(12):5009-22. PubMed ID: 24200695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffuse large B-cell lymphoma with histone H3 trimethylation at lysine 27: another poor prognostic phenotype independent of c-Myc/Bcl2 coexpression.
    Oh EJ; Yang WI; Cheong JW; Choi SE; Yoon SO
    Hum Pathol; 2014 Oct; 45(10):2043-50. PubMed ID: 25149548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MYC-driven malignant transformation of mature murine B cells requires inhibition of both intrinsic apoptosis and p53 activity.
    Högstrand K; Grandien A
    Eur J Immunol; 2019 Mar; 49(3):375-385. PubMed ID: 30281155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
    Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
    Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective inhibition of EZH2 by ZLD10A blocks H3K27 methylation and kills mutant lymphoma cells proliferation.
    Song X; Zhang L; Gao T; Ye T; Zhu Y; Lei Q; Feng Q; He B; Deng H; Yu L
    Biomed Pharmacother; 2016 Jul; 81():288-294. PubMed ID: 27261606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations.
    Guo S; Chan JK; Iqbal J; McKeithan T; Fu K; Meng B; Pan Y; Cheuk W; Luo D; Wang R; Zhang W; Greiner TC; Chan WC
    Clin Cancer Res; 2014 Jun; 20(12):3078-86. PubMed ID: 24634383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The many layers of epigenetic dysfunction in B-cell lymphomas.
    Jiang Y; Dominguez PM; Melnick AM
    Curr Opin Hematol; 2016 Jul; 23(4):377-84. PubMed ID: 27055146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
    Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
    Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications.
    Kim SH; Yang WI; Min YH; Ko YH; Yoon SO
    Tumour Biol; 2016 Feb; 37(2):2037-47. PubMed ID: 26337274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.
    Popovic R; Martinez-Garcia E; Giannopoulou EG; Zhang Q; Zhang Q; Ezponda T; Shah MY; Zheng Y; Will CM; Small EC; Hua Y; Bulic M; Jiang Y; Carrara M; Calogero RA; Kath WL; Kelleher NL; Wang JP; Elemento O; Licht JD
    PLoS Genet; 2014 Sep; 10(9):e1004566. PubMed ID: 25188243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma.
    Winkler R; Piskor EM; Kosan C
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The class-specific BCR tonic signal modulates lymphomagenesis in a c-myc deregulation transgenic model.
    Amin R; Marfak A; Pangault C; Oblet C; Chanut A; Tarte K; Denizot Y; Cogné M
    Oncotarget; 2014 Oct; 5(19):8995-9006. PubMed ID: 25229630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis.
    Vasanthakumar A; Lepore JB; Zegarek MH; Kocherginsky M; Singh M; Davis EM; Link PA; Anastasi J; Le Beau MM; Karpf AR; Godley LA
    Blood; 2013 Mar; 121(11):2059-63. PubMed ID: 23315164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response.
    Béguelin W; Teater M; Meydan C; Hoehn KB; Phillip JM; Soshnev AA; Venturutti L; Rivas MA; Calvo-Fernández MT; Gutierrez J; Camarillo JM; Takata K; Tarte K; Kelleher NL; Steidl C; Mason CE; Elemento O; Allis CD; Kleinstein SH; Melnick AM
    Cancer Cell; 2020 May; 37(5):655-673.e11. PubMed ID: 32396861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad.
    Frenzel A; Labi V; Chmelewskij W; Ploner C; Geley S; Fiegl H; Tzankov A; Villunger A
    Blood; 2010 Feb; 115(5):995-1005. PubMed ID: 19965635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells.
    Knutson SK; Wigle TJ; Warholic NM; Sneeringer CJ; Allain CJ; Klaus CR; Sacks JD; Raimondi A; Majer CR; Song J; Scott MP; Jin L; Smith JJ; Olhava EJ; Chesworth R; Moyer MP; Richon VM; Copeland RA; Keilhack H; Pollock RM; Kuntz KW
    Nat Chem Biol; 2012 Nov; 8(11):890-6. PubMed ID: 23023262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas.
    Tian X; Pelton A; Shahsafaei A; Dorfman DM
    Mod Pathol; 2016 Sep; 29(9):1050-7. PubMed ID: 27282353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice.
    Nemajerova A; Petrenko O; Trümper L; Palacios G; Moll UM
    J Clin Invest; 2010 Jun; 120(6):2070-80. PubMed ID: 20484818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis.
    Velichutina I; Shaknovich R; Geng H; Johnson NA; Gascoyne RD; Melnick AM; Elemento O
    Blood; 2010 Dec; 116(24):5247-55. PubMed ID: 20736451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas.
    Yamagishi M; Hori M; Fujikawa D; Ohsugi T; Honma D; Adachi N; Katano H; Hishima T; Kobayashi S; Nakano K; Nakashima M; Iwanaga M; Utsunomiya A; Tanaka Y; Okada S; Tsukasaki K; Tobinai K; Araki K; Watanabe T; Uchimaru K
    Cell Rep; 2019 Nov; 29(8):2321-2337.e7. PubMed ID: 31747604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.